In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on Envision Healthcare Holdings EVHC, but removed the $33.00 price target.
In the report, Morgan Stanley noted, “EVHC experienced a positive mix shift in January. Specifically, the company noted a positive shift of self-pay volumes to Medicaid in a ‘dozen or more' expansion states in January, with some reporting a few hundred bps shift with others at 300 to 400 bps. While the company stated it is too early to parse the data into Medicaid and Exchange buckets, we view the commentary as an early positive sign for reform.”
Envision Healthcare Holdings closed on Wednesday at $34.28.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in